JOURNAL BROWSE
Search
Advanced SearchSearch Tips
P16INK4a Immunostaining but Lack of Human Papilloma Virus Type 16 in Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma: a Report from West Iran
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
P16INK4a Immunostaining but Lack of Human Papilloma Virus Type 16 in Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma: a Report from West Iran
Ramezani, Mazaher; Abdali, Elham; Khazaei, Sedigheh; Vaisi-Raygani, Asad; Sadeghi, Masoud;
  PDF(new window)
 Abstract
The tumor suppressor p16 is a biomarker for transforming human papilloma virus (HPV) infections that can lead to contradictory results in skin carcinomas. The aim of this study was to evaluate p16 expression and HPV-16 infection in the cutaneous basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). This case-control study was performed on paraffin blocks of BCCs and SCCs and normal skin (53, 36, and 44 cases, respectively), between 2006 to 2015. Initial sections for groups were stained with hematoxylin and eosin (H & E). Immunohistochemistry was performed for p16 expression and human papilloma virus type 16 (HPV-16) infection. Normal group was skin of mammoplasty specimens and normal skin tissue in the periphery of tumors. The mean age at diagnosis was 42.1, 61.7 and 71.4 years for normal, BCC and SCC groups, respectively. P16 positivity was more in SCC and BCC groups compared to normal group (P<0.05) and HPV was negative in all patients in three groups. Also, the mean age at diagnosis and P16-positivity were higher for the SCC group than the BCC group (P<0.005). In conclusion, in non-melanoma skin cancers (SCC and BCC), p16-positivity can be a prognostic factor but there is no correlation between HPV-16 and p16 in these tumors.
 Keywords
Skin;P16;HPV-16;basal cell carcinoma;squamous cell carcinoma;
 Language
English
 Cited by
1.
Cutaneous Squamous Cell Carcinoma, Advances In Anatomic Pathology, 2017, 24, 4, 171  crossref(new windwow)
 References
1.
Alexander RE, Hu Y, Kum JB, et al (2012). p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma. Mod Pathol, 25, 1526-33. crossref(new window)

2.
Aumayr K, Susani M, Horvat R, et al (2013). P16INK4A immunohistochemistry for detection of human papilloma virus-associated penile squamous cell carcinoma is superior to in-situ hybridization. Int J Immunopathol Pharmacol, 26, 611-20.

3.
Bashir SA, Pandith AA, Yousuf A, et al (2010). Lack of p16 gene mutations in gastric cancers in Kashmir. Asian Pac J Cancer Prev, 11, 339-42.

4.
Bixofis RB, Sassi LM, Patussi C, et al (2014). Significance of p16 positive expression in oropharyngeal cancers. Asian Pac J Cancer Prev, 15, 10289-92

5.
Conscience I, Jovenin N, Coissard C, et al (2006). P16 is overexpressed in cutaneous carcinomas located on sun-exposed areas. Eur J Dermatol, 16, 518-22.

6.
Escutia B, Ledesma E, Serra-Guillen C, et al (2011). Detection of human papilloma virus in normal skin and in superficial and nodular basal cell carcinomas in immunocompetent subjects. J Eur Acad Dermatol Venereol, 25, 832-8. crossref(new window)

7.
Eshkoor SA, Ismail P, Rahman SA, Oshkour SA (2008). p16 gene expression in basal cell carcinoma. Arch Med Res, 39, 668-73. crossref(new window)

8.
Hodges A, Smoller BR (2002). Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin. Mod Pathol, 15, 1121-5. crossref(new window)

9.
Klussmann JP, Gultekin E, Weissenborn SJ, et al (2003). Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol, 162, 747-53. crossref(new window)

10.
Kumar R, Ghosh SK, Verma AK, et al (2015). p16 Expression as a surrogate marker for HPV infection in esophageal squamous cell carcinoma can predict response to neo-adjuvant chemotherapy. Asian Pac J Cancer Prev, 16, 7161-5. crossref(new window)

11.
Lewis JS Jr, Thorstad WL, Chernock RD, et al (2011). p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol, 35, 774-8.

12.
Lomas A, Leonardi-Bee J, Bath-Hextall F (2012). A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol, 166, 1069-80. crossref(new window)

13.
Mokhtari M, Mesbah A, Rajabi P, et al (2009). Determination of the relationship between Basal cell carcinoma and human papilloma virus, based on immunohistochemistry staining method. Indian J Dermatol, 54, 225-8. crossref(new window)

14.
Paolini F, Carbone A, Benevolo M, et al (2011). Human Papillomaviruses, p16INK4a and Akt expression in basal cell carcinoma. J Exp Clin Cancer Res, 30, 108. crossref(new window)

15.
Patil S, Rao RS, Amrutha N, Sanketh DS (2014). Analysis of human papilloma virus in oral squamous cell carcinoma using p16: An immunohistochemical study. J Int Soc Prev Community Dent, 4, 61-6. crossref(new window)

16.
Payette MJ, Whalen J, Grant-Kels JM (2010). Nutrition and nonmelanoma skin cancers. Clin Dermatol, 28, 650-62. crossref(new window)

17.
Ramshankar V, Soundara VT, Shyamsundar V, Ramani P, Krishnamurthy A (2014). Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression. Asian Pac J Cancer Prev, 15, 8351-9. crossref(new window)

18.
Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T (1998). Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol, 153, 1741-48. crossref(new window)

19.
Santos M, Montagut C, Mellado B, et al (2004). Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva. Int J Gynecol Pathol, 23, 206-14. crossref(new window)

20.
Shayanfar N, Hosseini N, Panahi M, et al (1013). Detection of mucosal type human papillomavirus in cutaneous squamous cell carcinoma in Iran. Pathol Res Pract, 209, 90-4. crossref(new window)

21.
Smeets SJ, Hesselink AT, Speel EJ, et al (2007). A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer, 121, 2465-72. crossref(new window)

22.
Tsoumpou I, Arbyn M, Kyrgiou M, Wentzensen N, Koliopoulos G, et al (2009). p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev, 35, 210-20. crossref(new window)

23.
Tufaro AP, Chuang JC, Prasad N, et al (2011). Molecular markers in cutaneous squamous cell carcinoma. Int J Surg Oncol, 2011, 231475.

24.
Zhu HL, Zou ZN, Lin PX, et al (2015). Malignant transformation rate and p53, and p16 expression in teratomatous skin of ovarian mature cystic teratoma. Asian Pac J Cancer Prev, 16, 1165-8. crossref(new window)